You are viewing the site in preview mode

Skip to main content


Figure 1 | BMC Infectious Diseases

Figure 1

From: Protective efficacy of recombinant canine adenovirus type-2 expressing TgROP18 (CAV-2-ROP18) against acute and chronic Toxoplasma gondii infection in mice

Figure 1

Schematic representation of the construction of recombinant plasmid pPolyII-CAV-E3-ROP18 by in vitro ligation. E3, the E3 region of CAV-2; CMV, human cytomegalovirus (hCMV) immediate-early gene promoter; polyA, the SV40 early mRNA polyadenylation signal. Bold letters were those enzymes used in plasmid construction.

Back to article page